HDAC9 and neoplasm: Moreover, research has shown that TMP195, an antagonist of HDAC, reduced tumor growth and metastasis by modulating TAMs into a tumoricidal phenotype; furthermore, TMP195 enhanced the antitumor effect of PD-1 treatment and chemotherapy (150).